SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.
How can microdialysis benefit drug development
In this interview, discover how Charles River uses the power of microdialysis for drug development as well as CNS therapeutics.